KIAA1524 Produkte
(KIAA1524)
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte KIAA1524 Kategorien
KIAA1524 Antikörper
High quality antibodies with extensive validation data.
KIAA1524 ELISA Kits
Reliable ELISA kits for a wide range of species.
KIAA1524 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene KIAA1524 Antikörper
- (2)
- (3)
- (1)
Empfohlene KIAA1524 ELISA Kits
- (1)
- (1)
Empfohlene KIAA1524 Proteine
Neueste Publikationen zu unseren KIAA1524 Produkten
: "Cancerous inhibitor of protein phosphatase 2A regulates cisplatin resistance in ovarian cancer." in: Oncology letters, Vol. 17, Issue 1, pp. 1211-1216, (2019) (PubMed).: "DAPK and CIP2A are involved in GAS6/AXL-mediated Schwann cell proliferation in a rat model of bilateral cavernous nerve injury." in: Oncotarget, Vol. 9, Issue 5, pp. 6402-6415, (2018) (PubMed).
: "CIP2A facilitates the G1/S cell cycle transition via B-Myb in human papillomavirus 16 oncoprotein E6-expressing cells." in: Journal of cellular and molecular medicine, Vol. 22, Issue 9, pp. 4150-4160, (2018) (PubMed).
: "ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer." in: Molecular oncology, Vol. 12, Issue 10, pp. 1706-1717, (2018) (PubMed).
: "Feedback between E2F1 and CIP2A regulated by human papillomavirus E7 in cervical cancer: implications for prognosis." in: American journal of translational research, Vol. 9, Issue 5, pp. 2327-2339, (2017) (PubMed).
: "CIP2A mediates prostate cancer progression via the c-MYC signaling pathway." in: Tumour biology, Vol. 36, Issue 5, pp. 3583-9, (2015) (PubMed).
: "Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1." in: Oncotarget, Vol. 6, Issue 7, pp. 5253-62, (2015) (PubMed).
: "Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma." in: Cancer medicine, Vol. 4, Issue 6, pp. 903-13, (2015) (PubMed).
: "Cancerous inhibitor of protein phosphatase 2A (CIP2A) is an independent prognostic marker in wild-type KRAS metastatic colorectal cancer after colorectal liver metastasectomy." in: BMC cancer, Vol. 15, pp. 301, (2015) (PubMed).
: "CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations." in: Oncotarget, Vol. 6, Issue 23, pp. 19661-70, (2015) (PubMed).
Synonyme und alternative Namen zu KIAA1524
cell proliferation regulating inhibitor of protein phosphatase 2A (CIP2A), RIKEN cDNA C330027C09 gene (C330027C09Rik), KIAA1524 (KIAA1524), cell proliferation regulating inhibitor of protein phosphatase 2A L homeolog (cip2a.L), CONSTANS interacting protein 2a (CIP2a), cell proliferation regulating inhibitor of protein phosphatase 2A (cip2a), cell proliferation regulating inhibitor of protein phosphatase 2A (Cip2a), AA408511, AU018569, CIP2A, Cip2a, Kiaa1524, KIAA1524, LOC100222895, p90, RGD1310335Bezeichner auf Proteinebene für KIAA1524
- cancerous inhibitor of PP2A
- p90 autoantigen
- protein CIP2A
- p90 autoantigen homolog
- protein CIP2A homolog
- KIAA1524
- CONSTANS interacting protein 2a
- hypothetical protein LOC100216050